Woman, who received the Moderna COVID-19 vaccine 3 weeks before delivery, had given birth to a baby with coronavirus antibodies.
Moderna Starts New COVID-19 Vaccine Trial
Biotechnology company Moderna announced that the first participants have been dosed in the Phase 1 study of mRNA-1283, the company's next generation COVID-19 vaccine candidate.
Biotechnology company Moderna announced that the first participants have been dosed in the Phase 1 study of mRNA-1283, the company's next generation COVID-19 vaccine candidate.
‘Maternal vaccination may have the potential to reduce COVID infection, as a woman in the United States who was 36-week pregnant having received the Moderna COVID-19 vaccine 3 weeks before delivery, had given birth to a baby with coronavirus antibodies. However further studies are required to confirm the protective efficacy in newborns and ideal timing of the Covid-19 vaccines in the pregnant and breastfeeding woman and their offspring.’
"Here, we report the first known case of an infant with SARS-CoV-2 IgG antibodies detectable in cord blood after maternal vaccination," says the co-authors, Paul Gilbert and Chad Rudnick from Florida Atlantic University in the US. It was noted that the woman has been breastfeeding the baby exclusively, and also received the second dose of the vaccine as per the normal 28-day vaccination protocol timeline.
Although the evidence on the passage of antibodies from COVID-recovered mothers to their foetuses via the placenta was limited earlier, the present research suggests "potential for protection and infection risk reduction from SARS-CoV-2 with maternal vaccination."
AstraZeneca's COVID-19 Vaccine Safe for Canadians above 65
Canada's National Advisory Committee on Immunization (NACI) announced on Tuesday that the Oxford-AstraZeneca COVID-19 vaccine is both safe and effective for people over age 65.
Canada's National Advisory Committee on Immunization (NACI) announced on Tuesday that the Oxford-AstraZeneca COVID-19 vaccine is both safe and effective for people over age 65.
"Protective efficacy in newborns and ideal timing of maternal vaccination remains unknown. We urge other investigators to create the pregnancy and breastfeeding registries as well as to conduct efficacy and safety studies of the Covid-19 vaccines in the pregnant and breastfeeding woman and their offspring," says the paediatricians in the study.
Advertisement
COVID-19 Vaccine Testing on Children
Moderna, the US-based Biotechnology company is now testing a COVID-19 vaccine designed to be used on children aged between 6 months to less than 12 years old.
Moderna, the US-based Biotechnology company is now testing a COVID-19 vaccine designed to be used on children aged between 6 months to less than 12 years old.
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
